BioPharma companies and Medical Device manufacturers face growing operational, regulatory and economic challenges. ICON provides analysis and key insights on these challenges, with practical advice and recommendations.
The traditional clinical development model needs to change.Explore
The traditional healthcare delivery model is changing.Explore
Technologies that accelerate and improve Clinical Trials.Explore
Patients are now better informed on clinical options than they ever have been.Explore
A new survey of pharmaceutical executives and professionals by ICON and Pharma Intelligence.
Remote monitoring and leveraging wearable devices and sensors in clinical trials.
Understand and successfully address the complexities of adaptive trial design.
BYOD promises greater patient-centricity and will make study management less complex.
ICON and ICHOM working to develop risk-adjusted, international benchmarks on health outcomes by medical condition.
Learn how you can leverage these systems to benefit observational studies and clinical trials.
Discover how sponsors can respond to new business risks and opportunities in a value-based payment environment with this white paper.
ICON whitepaper which deconstructs the critical challenges to achieving mandates for cost efficiency and productivity.
Discover the best methods for mitigating anticipated delays and increased costs in this new regulatory environment.
Cybersecurity vulnerabilities can emerge in any medical device that can be connected to another electronic device or network.
An adaptive design clinical trial can help to create a stronger value proposition for your medical device by reducing development costs and accelerating time-to-market.
ICON sponsored research outlines partnership strategies to optimise clinical drug development.
Look to the future of immuno-oncology, and foresee emerging challenges in drug development as well as growing treatment options in our complimentary white paper.
Technology innovations can enable faster collection, standardisation, and analysis of real world data assets. Learn how sponsors can take full advantage of these innovations.